Peer-influenced content. Sources you trust. No registration required. This is HCN.
Endocrinology Advisor
Insulin may be a stronger predictor than BMI for certain outcomes, particularly androgenic hormone changes and vasomotor symptom incidence.
Endocrinology, Diabetes, Metabolism February 11th 2026
Medical Professionals Reference (MPR)
Findings from both trials showed treatment with elinzanetant led to a statistically significant reduction (≥2 hot flashes over 24 hours) in the frequency of moderate to severe VMS compared with placebo at both 4 and 12 weeks across OASIS 1 and 2 studies.
Obstetrics & Gynecology November 11th 2025
Conexiant
Assessment highlights a disconnect between the pharmacokinetic expectations of the three-month estradiol vaginal ring and the lived experience of some patients using it, which in some cases greatly impacts the quality of life.
Endocrinology, Diabetes, Metabolism October 24th 2025